Director · MAIA Biotechnology, Inc. · Common Stock
Side
BUY
Value
$2,386
Shares
1,794
Price
$1.33
Executed
Aug 24, 2026
Disclosed
Aug 26, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 24 executedAug 26, 2026 disclosed
MAIA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Guerrero Ramiro filed this Form 4 reporting a open-market purchase of MAIA on Aug 24, 2026. It became public on Aug 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Guerrero Ramirocik:0001913253
Issuer
MAIA Biotechnology, Inc.cik:0001878313
Revision history · 0
No field has changed since this record was first ingested.
